RecruitingPhase 1Phase 2NCT07451613

Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease

Phase 1B/2A Study of the Safety and Tolerability of Human Neural Stem Cells for Huntington's Disease

Sponsor

Leslie Thompson

Enrollment

21 participants

Start Date

Apr 6, 2026

Study Type

INTERVENTIONAL

Conditions

Huntington Disease

Summary

The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called hNSC-01 for people with huntington disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALhNSC-01

neural stem cell therapy

Locations(1)

University of California, Irvine

Irvine, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07451613

Related Trials

Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease

NCT073786448 locations

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

NCT0732670920 locations

Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

NCT0666741445 locations

A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease

NCT068266125 locations

Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease

NCT075138441 location